The Quality Use of Pathology Committee (QUPC) is responsible for overseeing the Quality Use of Pathology Program (QUPP) and providing advice in relation to strategic directions and projects implemented under the program.
The QUPC is comprised of nominees from the pathology profession, medical profession, consumer groups, educational institutions and representatives from the Department of Health. Members and their organisations are listed below.
|Dr Michael Harrison||Chair|
|Dr Kevin Carpenter||Australasian Association of Clinical Biochemists|
|Mr Michael Lynch||Australian Institute of Medical Scientists|
|A/Prof Beverley Rowbotham||Australian Medical Association|
|Dr Michael Page||Australian Medical Association|
|Ms Diane Walsh||Consumers Health Forum|
|Mrs Toni Rice||Consumers Health Forum|
|Professor Peter Smith||Medical Deans of Australia and New Zealand|
|Dr Daniel Owens||Pathology Australia|
|Professor Robert Lindeman||Public Pathology of Australia|
|Dr Trina Gregory||Royal Australian College of General Practitioners|
|Dr Oliver Frank||Royal Australian College of General Practitioners|
|Dr Tracey Batt||Royal Hobart Hospital|
|Dr Lawrie Bott||Royal College of Pathologists of Australasia|
QUPC also includes two ex-officio members from the Department and an independent chairperson.
Secretariat support for the QUPC is provided by the Pathology Quality Section of the Diagnostic Imaging and Pathology Branch.
Role of the QUPC
Each member is appointed on the basis of their individual skills, knowledge and expertise. Their role is to provide advice to the Department of Health on issues relating to the QUPP.
QUPC Terms of Reference
The Terms of Reference for the QUPC are to:
- oversee and provide advice to Government in relation to strategic directions and proposed projects and initiative under the QUPP;
- provide advice to assist the Department with the QUPP funding allocation in line with QUPP priorities and the objectives of the Pathology Funding Agreement (PFA);
- provide commentary on QUPP potential projects/initiatives, project applications, and on completed projects/initiatives;
- assist the Department and the Pathology Agreement Advisory Committee (PAAC) with the evaluation of QUPP investment to date; and to
- adopt and maintain a comprehensive and effective communication strategy to promote awareness of the quality use of pathology both within and outside of the pathology industry and profession.
: The Terms of Reference are still current. However, the references to the PFA and PAAC are no longer applicable.
The contact details for the QUPC Secretariat are as follows:
Pathology Quality Section
Department of Health
GPO Box 9848 (MDP 851)
Canberra ACT 2601